YOUR BUSINESS AUTHORITY
Springfield, MO
AstraZeneca is in talks to combine with Bristol Myers Squibb, people familiar with the matter told the Financial Times.
The proposed deal is reportedly valued at nearly $400 billion.
The companies have held discussions about a tie-up in recent months, the sources said.
Read more from the Financial Times.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year